首页 | 本学科首页   官方微博 | 高级检索  
     


A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra‐cranial solid tumors: A Children's Oncology Group Phase I Consortium report
Authors:E . Anders Kolb MD  Valerie Sampson PhD  Deborah Stabley BS  Alexa Walter  Katia Sol‐Church PhD  Timothy Cripe MD  PhD  Pooja Hingorani MD  Charlotte Hsieh Ahern PhD  Brenda J. Weigel MD  James Zwiebel MD  Susan M. Blaney MD
Affiliation:1. Nemours Center for Cancer and Blood Disorders, Nemours/A.I. duPont Jospital for Children, Wilmington, Delaware;2. Nemours Biomolecular Core Laboratory, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware;3. Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio;4. Division of Hematology and Oncology, Phoenix Children's Hospital, Phoenix, Arizona;5. Department of Medicine, Division of Biostatistics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, Texas;6. Division of Hematology and Oncology, University of Minnesota, Amplatz Children's Hospital, Minneapolis, Minnesota;7. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland;8. Division of Hematology‐Oncology, Department of Medicine, Baylor College of Medicine, Texas Children's Cancer Center, Houston, Texas
Abstract:
Keywords:phase 1  pediatric cancer  pirotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号